NCT05633368View on ClinicalTrials.gov

Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2020

Primary Completion Date

June 19, 2020

Study Completion Date

June 19, 2020

Conditions
Electroconvulsive TherapyMajor Depressive DisorderCovid-19
Interventions
OTHER

Questionnaires

"Participants will be contacted every three weeks to assess depressive symptomatology and possible relapse.~* Patient Health Questionnaire (PHQ-9)~* Clinical Global Impression (CGI)~* Scaling question regarding depressive symptomatology"

Trial Locations (2)

8500

AZ Groeninge, Kortrijk

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT05633368 - Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy | Biotech Hunter | Biotech Hunter